Publication | Open Access
<p>Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling</p>
28
Citations
46
References
2020
Year
The results of this study indicate that foretinib could be a therapeutic agent for the prevention or treatment of GCs positive for CD44v9 and c-MET.
| Year | Citations | |
|---|---|---|
Page 1
Page 1